AIFD Strategy Meeting 2025 Held in Ankara
26.09.2025
The Association of Research-Based Pharmaceutical Companies (AIFD) held its traditional Strategy Meeting on September 24, 2025, in Ankara, as part of its ongoing vision to ensure timely and sustainable access to innovative medicines and treatments in Türkiye.
Attended by the AIFD Board of Directors, general managers of member companies, and the AIFD team, the meeting provided a valuable platform to assess current developments in the pharmaceutical sector, engage in dialogue with public authorities, and shape a joint roadmap for the future.
We extend our sincere gratitude to the following esteemed representatives of public institutions for their presence and contributions:
Assoc. Prof. Dr. Şuayıp Birinci, Deputy Minister, Ministry of Health
Kutluhan Taşkın, Deputy President, Presidency of Strategy and Budget
Ahmet Selim Köroğlu, Chief Advisor to the President, Member of the Presidential Health Policies Board
Prof. Dr. Gülçin Sarıyıldız, Member of the Presidential Health Policies Board
Ahmet Oğuz Sarıca, Coordinator of Economic Affairs, Presidency Vice Presidency Office
Prof. Dr. Ahmet Ayar, President, Turkish Medicines and Medical Devices Agency (TİTCK)
Assoc. Prof. Dr. Eren Usul, Director General of General Health Insurance, Social Security Institution
Celalettin Sıvacı and Ali Mercan Aydın, Deputy Directors General, Public Financial Management and Transformation, Ministry of Treasury and Finance
Osman Nuri Erdem, Director General of Plans and Programs, Presidency of Strategy and Budget
Prof. Dr. Burak Civelek, President, Turkish Cancer Institute, TÜSEB
AIFD remains committed to strengthening cooperation and open dialogue channels to expand access to innovative therapies and support the advancement of Türkiye’s healthcare ecosystem.